Published in Ann N Y Acad Sci on December 29, 1995
Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. FASEB J (2008) 1.24
Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition. J Clin Endocrinol Metab (2009) 1.22
Dehydroepiandrosterone sulfate and longevity: new clues for an old friend. Proc Natl Acad Sci U S A (2001) 0.96
Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) Trial. J Am Geriatr Soc (2008) 0.91
The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor beta 1 (TGF-beta1) levels in normal healthy blood donors. Clin Exp Immunol (1999) 0.86
A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? Rejuvenation Res (2013) 0.85
Hormone replacement for men. BMJ (1996) 0.79
Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women. Arch Womens Ment Health (2009) 0.78
DHEA: panacea or snake oil? Can Fam Physician (1999) 0.76
Acute Effects of Oral Dehydroepiandrosterone on Counterregulatory Responses During Repeated Hypoglycemia in Healthy Humans. Diabetes (2016) 0.75
Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. Fertil Steril (1993) 2.09
An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J Biol Chem (1997) 1.73
Treatment of endometriosis with the antiprogesterone mifepristone (RU486) Fertil Steril (1996) 1.48
A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol (1995) 1.39
Characterizing and modeling an electoral campaign in the context of Twitter: 2011 Spanish Presidential election as a case study. Chaos (2012) 1.33
Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab (1997) 1.22
Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. J Clin Endocrinol Metab (1997) 1.16
Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab (1993) 1.15
Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect. Fertil Steril (1995) 1.14
Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril (1995) 1.04
Lysophosphatidyl choline, a chemotactic factor for monocytes/T-lymphocytes is elevated in endometriosis. J Clin Endocrinol Metab (1998) 1.02
Autoantibodies to markers of oxidative stress are elevated in women with endometriosis. Fertil Steril (1999) 0.99
The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study. Am J Obstet Gynecol (1994) 0.98
Simultaneous binding of two proteins to opposite sides of a single transfer RNA. Nat Struct Biol (2001) 0.96
Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids. Hum Reprod (1994) 0.96
Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity. J Clin Endocrinol Metab (1997) 0.95
Possible negative ultra-short loop feedback of luteinizing hormone releasing hormone (LHRH) in the ovariectomized rat. Proc Soc Exp Biol Med (1985) 0.92
GnRH antagonists followed by a decline in serum estradiol results in adverse outcomes in donor oocyte cycles. Hum Reprod (2003) 0.91
Functional redundancy in the nonspecific RNA binding domain of a class I tRNA synthetase. J Biol Chem (2000) 0.90
Fever-specific changes in central MSH and CRF concentrations. Am J Physiol (1985) 0.90
Crystal structure of trbp111: a structure-specific tRNA-binding protein. EMBO J (2000) 0.88
Antioxidant: a new role for RU-486 and related compounds. J Clin Invest (1994) 0.88
Evidence for oxidatively modified lipid-protein complexes in endometrium and endometriosis. Fertil Steril (1998) 0.88
Fungi and humans: closer than you think. Trends Genet (2001) 0.86
Physiological role of alpha-melanocyte-stimulating hormone in modulating the secretion of prolactin and luteinizing hormone in the female rat. Proc Natl Acad Sci U S A (1984) 0.84
Bimodal effects of neuropeptide Y on hypothalamic release of gonadotropin-releasing hormone in conscious rabbits. Neuroendocrinology (1987) 0.83
Role of arginine vasopressin in control of ACTH and LH release during stress. Life Sci (1985) 0.83
Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women. J Gerontol A Biol Sci Med Sci (2000) 0.82
Blockade of stress-induced prolactin release in monosodium glutamate-treated rats. Brain Res Bull (1983) 0.82
Macrophage scavenger receptor(s) and oxidatively modified proteins in endometriosis. Fertil Steril (1998) 0.81
The role of brain peptides in neuroimmunomodulation. Ann N Y Acad Sci (1987) 0.80
Recent studies on the role of brain peptides in control of anterior pituitary hormone secretion. Peptides (1984) 0.80
Changes in hypothalamic and pituitary content of immunoreactive alpha-melanocyte-stimulating hormone during the gestational and postpartum periods in the rat. Proc Soc Exp Biol Med (1984) 0.79
Central administration of alpha-MSH antiserum augments fever in the rabbit. Am J Physiol (1986) 0.79
Interface between extra- and intraovarian factors in polycystic ovarian syndrome. Ann N Y Acad Sci (1993) 0.79
Effect of alpha-melanocyte-stimulating hormone on basal and stimulated release of prolactin: evidence for dopaminergic mediation. Neuroendocrinology (1982) 0.79
Role of opioid peptides in pulsatile release of gonadotropins and prolactin in the rat. Brain Res Bull (1987) 0.79
Partial characterization of immunoreactive substance P in the rat pituitary gland. Life Sci (1984) 0.78
Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486). Am J Obstet Gynecol (1998) 0.78
Stress-induced secretion of alpha-melanocyte-stimulating hormone and its physiological role in modulating the secretion of prolactin and luteinizing hormone in the female rat. Endocrinology (1985) 0.78
Hypothalamic control of prolactin secretion during the perinatal period in the rat. Endocrinology (1984) 0.78
The effect and possible mode of action of alpha-melanocyte-stimulating hormone on gonadotropin release in the ovariectomized rat: an in vivo and in vitro analysis. Endocrinology (1984) 0.78
On the presence of a nondopaminergic, peptidergic prolactin release-inhibiting factor in hypothalamic extracts of infantile rats. Neuroendocrinology (1986) 0.78
Development of hypothalamic control of growth hormone secretion in the rat. Endocrinology (1983) 0.78
Regulation of insulin-like growth factor binding protein-1 during the 24-hour metabolic clock and in response to hypoinsulinemia induced by fasting and Sandostatin in normal women. J Soc Gynecol Investig (1998) 0.78
The measurement of neuropeptide Y in discrete hypothalamic and limbic regions of male rhesus macaques with a human NPY-directed antiserum. Peptides (1987) 0.78
Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome. Metabolism (1998) 0.78
Interaction of alpha-melanocyte-stimulating hormone with beta-endorphin to influence anterior pituitary hormone secretion in the female rat. Endocrinology (1986) 0.77
Prior oral contraceptive use is associated with higher blood pressure in older women. J Womens Health (1998) 0.77
Endometrial effects of long-term low-dose administration of RU486. Fertil Steril (1995) 0.77
Purification of a non-dopaminergic and non-GABAergic prolactin release-inhibiting factor (PIF) in sheep stalk-median eminence. Proc Soc Exp Biol Med (1985) 0.77
The influence of suckling on the hypothalamic and pituitary secretion of immunoreactive alpha-melanocyte stimulating hormone. Brain Res (1986) 0.77
Age-, sex-, and gonadal steroid-related changes in immunoreactive substance P in the rat anterior pituitary gland. Endocrinology (1985) 0.76
Circulating levels of follistatin from puberty to menopause. Fertil Steril (1996) 0.76
The effect of the estrous cycle and estrogen on the release of immunoreactive alpha-melanocyte-stimulating hormone. Peptides (1986) 0.76
Pre- and postnatal developmental changes in hypothalamic and pituitary content of alpha-melanocyte-stimulating hormone and somatostatin in the rat. Biol Neonate (1984) 0.75
The effect of tubero-infundibular dopaminergic neurons on prolactin and alpha-melanocyte stimulating hormone release. Braz J Med Biol Res (1991) 0.75
Simultaneous induction of neuropeptide Y and gonadotropin-releasing hormone release in the rabbit hypothalamus. Neuroendocrinology (1989) 0.75
The bingo model of survivorship. II: statistical aspects of the bingo model of multiplicity 1 with application to hereditary polyposis of the colon. Am J Med Genet (1984) 0.75
Alpha-melanocyte stimulating hormone discloses a stimulatory effect of beta-endorphin on somatostatin release. Brain Res (1987) 0.75
Evidence-based medicine: study design for evaluation of treatment. J Am Assoc Gynecol Laparosc (1998) 0.75
Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DS) as therapeutic options in menopause. Semin Reprod Endocrinol (1998) 0.75
Growth factors and polycystic ovarian syndrome. Semin Reprod Endocrinol (1996) 0.75
Infertility in women. Curr Ther Endocrinol Metab (1997) 0.75
The development of prolactin, growth hormone, alpha-melanocyte-stimulating hormone and monoaminergic systems in the rat. Monogr Neural Sci (1986) 0.75
Operative ultrasound using an echogenic loop snare for intrauterine pathology. J Am Assoc Gynecol Laparosc (2003) 0.75
Comparison of sonohysterography and hysteroscopy: lessons learned and avoiding pitfalls. J Am Assoc Gynecol Laparosc (2002) 0.75